COSENTYX 150 mg, powder for solution for injection bottle
Active ingredients: SÉCUKINUMAB
Commercialized according to BDPMDispensing in France: Prescription only
Powder for solution for injectionbottlesous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- COSENTYX 150 mg, poudre pour solution injectable
- Pharmaceutical form
- poudre pour solution injectable
- Route of administration
- sous-cutanée
- Presentation description
- 1 flacon(s) en verre
- Marketing authorisation holder
- NOVARTIS EUROPHARM (IRLANDE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 22 Jul 2022
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62420687CIP73001059CIP133400930010594Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| SÉCUKINUMABpoudre | 150 mg · un flacon | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.